Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 14,084 | 183,363 | -157,924 | -161,381 | -161,867 |
| Depreciation Amortization | 2,341 | 2,402 | 2,355 | 2,405 | 2,068 |
| Income taxes - deferred | -33,788 | -185,495 | 11 | 4,361 | -3,156 |
| Accounts receivable | -8,606 | -8,675 | -3,910 | N/A | N/A |
| Accounts payable and accrued liabilities | 347 | 6,031 | 1,366 | -4,969 | -4,705 |
| Other Working Capital | 1,350 | -22,575 | 689 | -4,315 | -17,351 |
| Other Operating Activity | 37,573 | 30,756 | 31,115 | 27,367 | 26,642 |
| Operating Cash Flow | $13,301 | $5,807 | $-126,298 | $-136,532 | $-158,369 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -29,427 | -8,064 | 149,050 | -23,161 | 52,417 |
| PPE Investments | -130 | -14 | -415 | -283 | -3,203 |
| Purchase Sale Intangibles | N/A | N/A | -20,000 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -20,000 | 0 | 0 |
| Investing Cash Flow | $-29,557 | $-8,078 | $128,635 | $-23,444 | $49,214 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,701 | 3,417 | 5,885 | 228,222 | 84,225 |
| Other Financing Activity | -2,206 | -901 | 0 | -1,136 | -118 |
| Financing Cash Flow | $1,495 | $2,516 | $5,885 | $227,086 | $84,107 |
| Beginning Cash Position | 122,715 | 122,470 | 114,248 | 47,138 | 72,186 |
| End Cash Position | 107,954 | 122,715 | 122,470 | 114,248 | 47,138 |
| Net Cash Flow | $-14,761 | $245 | $8,222 | $67,110 | $-25,048 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,301 | 5,807 | -126,298 | -136,532 | -158,369 |
| Capital Expenditure | -130 | -105 | -415 | -283 | -3,203 |
| Free Cash Flow | 13,171 | 5,702 | -126,713 | -136,815 | -161,572 |